Tesofensine

Tesofensine — a triple-monoamine-reuptake-inhibitor research compound — supplied by BioFusion as a vacuum-sealed lyophilized vial for monoamine-pathway research chemistry.

Research context

Tesofensine is one of the most-cited reference compounds in monoamine-reuptake research published since 2018. As a small-molecule research reference, it is studied for its triple-reuptake-inhibitor profile (serotonin, norepinephrine, dopamine) and its place in the broader CNS-research-chemistry literature. Frequently appears in comparative pharmacology research panels as the canonical triple-reuptake reference standard.

Synthesis & documentation

Tesofensine is a small-molecule research compound (not a peptide); BioFusion supplies it as a lyophilized solid via multi-stage purification with reverse-phase HPLC isolation. Each lot is verified for identity (LC-MS), purity (HPLC-UV ≥99.0%), and moisture (Karl Fischer). The signed Certificate of Analysis ships with every order. The COA reading guide applies equally to small-molecule references.

Storage & handling

Lyophilized Tesofensine is stable at −20 °C for the printed shelf life. After reconstitution in DMSO, ethanol, or water (per protocol), reference-stability data supports use within fourteen days at 2-8 °C, protected from light. The BioFusion reconstitution calculator handles concentration math for both peptide and small-molecule references.

Why BioFusion

Small-molecule research compounds are vulnerable to identity drift if stored improperly or sourced through opaque supply chains. BioFusion publishes lot synthesis-date and HPLC-purity on the batch transparency ledger, releases COAs through the COA library, and ships domestically with no offshore re-labeling. Bulk discounts trigger at three+ vials; members save 25% on every order plus complimentary U.S. shipping for 365 days.

For research and laboratory use only. This product is not a drug, food, or cosmetic, and is not intended for diagnostic, therapeutic, or in vivo human use.